159
Francisca Pulido
El uso de BMP-2 en Traumatología. Avances en Ingeniería Tisular
bone morphogenetic protein in congenital pseudarthrosis of the tibia in
children: a case series and meta-analysis. 2012; 6(4):297-306.
23. Garrison KR, Shemilt I, Donell S, et al. Bone morphogenetic
protein (BMP) for fracture healing in adults. Cochrane Database Syst Rev.
2010; (6):CD006950.
24. Aro HT, Govender S, Patel AD, et al. Recombinant human bone
morphogenetic protein-2: a randomized trial in open tibial fractures treat-
ed with reamed nail fixation. J Bone Joint Surg Am. 2011; 93(9):801-8.
25. Mehta V. Bone morphogenetic proteins for tendon injuries: an
orthopedic primer. Am J Orthop (Belle Mead NJ). 2005; 34(9):451-4.
26. Bostrom M, Lane JM, Tomin E, et al. Use of bone morphoge-
netic protein-2 in the rabbit ulnar nonunion model. Clin Orthop Relat Res.
1996; 327:272-82.
27. Jones NF, Brown EE, Mostofi A, Vogelin E, Urist MR. Healing of
a scaphoid nonunion using human bone morphogenetic protein. J Hand
Surg Am. 2005; 30(3):528-33.
28. Johnson EE, Urist MR. One-stage lengthening of femoral non-
union augmented with human bone morphogenetic protein. Clin Orthop
Relat Res. 1998; 347:105-16.
29. Johnson EE, Urist MR, Finerman GA. Distal metaphyseal tibial
nonunion. Deformity and bone loss treated by open reduction, internal
fixation, and human bone morphogenetic protein (hBMP). Clin Orthop
Relat Res. 1990; 250:234-40.
30. Benglis D, Wang MY, Levi AD. A comprehensive review of the
safety profile of bone morphogenetic protein in spine surgery. Neurosur-
gery. 2008; 62(5 Suppl 2):ONS423-31.
31. Singh K, Dumonski M, Stanley T, Ponnappan R, Phillips FM. Re-
peat use of human recombinant bone morphogenetic protein-2 for sec-
ond level lumbar arthrodesis. Spine (Phila Pa 1976). 2011; 36(3):192-6.
32. Dawson E, Bae HW, Burkus JK, Stambough JL, Glassman SD.
Recombinant human bone morphogenetic protein-2 on an absorbable
collagen sponge with an osteoconductive bulking agent in posterolateral
arthrodesis with instrumentation. A prospective randomized trial. J Bone
Joint Surg Am. 2009; 91(7):1604-13.
33. Dimar JR 2nd, Glassman SD, Burkus JK, Pryor PW, Hardacker JW,
Carreon LY. Clinical and radiographic analysis of an optimized rhBMP-2
formulation as an autograft replacement in posterolateral lumbar spine
arthrodesis. J Bone Joint Surg Am. 2009; 91(6):1377-86.
34. Even J, Eskander M, Kang J. Bone morphogenetic protein in
spine surgery: current and future uses. J Am Acad Orthop Surg. 2012;
20(9):547-52.
35. Dmitriev AE, Lehman RA Jr, Symes AJ. Bone morphogenetic pro-
tein-2 and spinal arthrodesis: the basic science perspective on protein inter-
action with the nervous system. Spine J. 2011; 11(6):500-5.
36. Carragee EJ, Hurwitz EL, Weiner BK. A critical review of recombi-
nant human bone morphogenetic protein-2 trials in spinal surgery: emerg-
ing safety concerns and lessons learned. Spine J. 2011; 11(6):471-91.
37. Hsu WK, Wang JC. The use of bone morphogenetic protein in
spine fusion. Spine J. 2008; 8(3):419-25.
38. Kaps C, Bramlage C, Smolian H, et al. Bone morphogenetic pro-
teins promote cartilage differentiation and protect engineered artificial
cartilage from fibroblast invasion and destruction. Arthritis Rheum 2002;
46:149-62.
39. Huang Z, Ren PG, Ma T, Smith RL, Goodman SB. Modulating os-
teogenesis of mesenchymal stem cells by modifying growth factor availa-
bility. Cytokine. 2010; 51:305-10.
40. Noel D, Gazit D, Bouquet C, Apparailly F, et al. Short-term BMP-2
expression is sufficient for in vivo osteochondral differentiation of mesen-
chymal stem cells. Stem Cells. 2004; 22:74-85.
41. Shu B, Zhang M, Xie R, et al. BMP2, but not BMP4, is crucial
for chondrocyte proliferation and maturation during endochondral bone
development. J Cell Sci. 2011; 124:3428-40.
42. Chen G, Deng C, Li YP. TGF-beta and BMP signaling in osteoblast
differentiation and bone formation. Int J Biol Sci. 2012; 8(2):272-88.
43. Jansen JA, Vehof JWM, Ruhe PZ, et al. Growth-factor loaded sca-
ffolds for bone engineering. J Control Release. 2005; 101:127–36.
44. Gaalen SV, Kruyt M, Meijer G, et al. Tissue engineering of bone.
In: Blitterswijk CV, Thomsen P, Williams D, Hubbell J, Cancedda R, Bruijn
JD, et al., editors. editors. Tissue Engineering: United Kingdom; Elsevier
Inc; 2008; 559-610.
45. Srinivasan PP, McCoy SY, Jha AK, et al. Injectable perlecan do-
main 1-hyaluronan microgels potentiate the cartilage repair effect of
BMP2 in a murine model of early osteoarthritis. Biomed Mater. 2012;
7(2):024109.
46. Cha BH, Kim JH, Kang SW, et al. Cartilage tissue formation from
dedifferentiated chondrocytes by codelivery of BMP-2 and SOX-9 genes
encoding bicistronic vector. Cell Transplant. 2012; 5.
47. Kao DW, Kubota A, Nevins M, Fiorellini JP. The negative effect
of combining rhBMP-2 and Bio-Oss on bone formation for maxillary sinus
augmentation. Int J Periodontics Restorative Dent. 2012; 32(1):61-7.
48. Nishizaki K, Tsujigiwa H, Takeda Y, et al. Mastoid obliteration by
BMP-2/collagen composites: an experimental study using tissue engineer-
ing. Am J Otolaryngol. 2003; 24(1):14-8.
49. Ilić J, Radović K, Roganović J, Brković B, Stojić D. The levels of
vascular endothelial growth factor and bone morphogenetic protein
2 in dental pulp tissue of healthy and diabetic patients. J Endod. 2012;
38(6):764-8.
